AlphaYouRC
Insider buying
Ra Capital Management, L.P. bought $2.6M of Artiva Biotherapeutics, Inc. (ARTV) stock
Ra Capital Management, L.P., Dir, 10% of Artiva Biotherapeutics, Inc. (ARTV), bought 264,586 shares of ARTV stock worth $2.6M, per an SEC Form 4 filed Jul 24, 2026.
It was an open-market purchase.
The trade happened on Jul 21, 2026, 3 days before it was made public.
ARTV has moved -21.7% since the trade date, from $10.00 to $7.83 (Sep 21, 2026 close).
- Traded
- Jul 21, 2026
- Disclosed
- Jul 24, 2026
- Filing delay
- 3 days
- Price since
- -21.7%
- Role
- Dir, 10%
- Source
- SEC Form 4
More ARTV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.